{
  "id": 7308467,
  "title": "Scholar Rock gets FDA nod for spinal muscular atrophy drug",
  "url": "https://urgent.news/2026/09/14/scholar-rock-gets-fda-nod-for-spinal-muscular-atrophy-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-14T11:29:31.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/scholar-rock-gets-fda-nod-for-spinal-muscular-atrophy-drug/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Scholar Rock has won FDA approval for its drug treating a rare muscle-wasting disease, after facing delays due to a troubled manufacturing factory. The injectable drug apitegromab, branded as Isembyld, was",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 4,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: Scholar Rock wins FDA approval for first drug to target SMA muscle loss",
        "url": "https://urgent.news/2026/09/11/stat-scholar-rock-wins-fda-approval-for-first-drug-to-target-sma",
        "published": "2026-09-11T23:30:21.000Z"
      },
      {
        "outlet": "Seeking Alpha News",
        "title": "Scholar Rock jumps 12% after FDA approves isembyld for spinal muscular atrophy",
        "url": "https://urgent.news/2026/09/13/scholar-rock-jumps-12-after-fda-approves-isembyld-for-spinal-muscular",
        "published": "2026-09-13T17:32:30.000Z"
      },
      {
        "outlet": "BioPharma Dive",
        "title": "Scholar Rock SMA drug approved by FDA",
        "url": "https://urgent.news/2026/09/14/scholar-rock-sma-drug-approved-by-fda",
        "published": "2026-09-14T13:00:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}